Drs. Anglade and Sherlag Treat First Patient with the Urolift® System

Innovative UroLift System to Treat Enlarged Prostate Now Available at Georgia Urology

Lawrenceville, GA-July 18, 2014 – Georgia Urology  announced today that their first patient has been treated with the UroLift® System, the first permanent implant to treat symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men 50 years of age or older. Cleared by the U.S. Food and Drug Administration in 2013, the UroLift System is designed to relieve symptoms caused by an enlarged prostate, while preserving sexual function.

“Georgia Urology is committed to providing patients with the highest quality, most effective options to address their urology needs,” said Dr. Ronald Anglade of Georgia Urology. “The UroLift System has an excellent safety profile and provides men suffering from an enlarged prostate a beneficial first-line treatment alternative to drug therapy or more invasive surgery. Importantly, the UroLift System provides fast and meaningful relief from BPH symptoms, improving overall quality of life for our patients.”

The UroLift System permanent implants, delivered during a minimally-invasive procedure, act like window curtain tie-backs to hold the lobes of an enlarged prostate open. Patients recover from the procedure quickly, and return to their normal routines with minimal downtime.

Data from clinical trials showed that patients receiving UroLift implants reported rapid symptomatic improvement, improved urinary flow rates, and sustained sexual function with minimal adverse events, which mostly resolved two to four weeks following the procedure.  Patients also experienced a significant improvement in quality of life.